PPD, a leader in clinical research, has received a CRO Leadership Award for the 13th consecutive year in recognition of its dedication to innovation and excellence. The company’s annual innovation panel at the Drug Information Association (DIA) highlighted the importance of real-world data (RWD) and technology in accelerating drug development.
PPD’s panel on “Accelerating Drug Development through the Convergence of RWD and Technology” showcased how the increasing availability of RWD and advancements in artificial intelligence and wearable devices have enabled the utilization of real-world evidence (RWE) in drug development. This intersection provides valuable insights, empowering researchers to make informed decisions and optimize product development.
With a comprehensive offering of drug development services, PPD supports pharmaceutical and biotech companies throughout their drug development journey. The company’s integrated CRO and CDMO solutions provide a range of capabilities to streamline the process from molecule to medicine.
PPD’s expertise was recognized in all five categories of the CRO Leadership Awards: capabilities, compatibility, expertise, quality, and reliability. This honor underscores the company’s commitment to delivering exceptional service and partnership to its customers.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
